| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.020 | 9.972 | 10.658 | 11.884 | 15.608 | 13.962 | 14.542 | 17.835 | 20.201 | 30.585 |
| Total Income - EUR | 11.023 | 9.972 | 10.658 | 36.640 | 30.359 | 31.081 | 21.617 | 24.933 | 27.276 | 33.601 |
| Total Expenses - EUR | 13.542 | 13.160 | 17.422 | 25.187 | 25.340 | 22.270 | 19.265 | 21.993 | 25.195 | 29.584 |
| Gross Profit/Loss - EUR | -2.519 | -3.188 | -6.764 | 11.453 | 5.019 | 8.811 | 2.352 | 2.940 | 2.081 | 4.016 |
| Net Profit/Loss - EUR | -2.849 | -3.325 | -6.870 | 11.087 | 4.715 | 8.521 | 2.136 | 2.691 | 1.809 | 3.687 |
| Employees | 1 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Euroclin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 32.171 | 31.100 | 29.766 | 29.119 | 27.950 | 26.687 | 25.207 | 25.265 | 25.980 | 116.774 |
| Current Assets | 6.562 | 5.362 | 4.769 | 5.318 | 6.301 | 5.517 | 4.693 | 7.334 | 7.594 | 26.140 |
| Inventories | 5.176 | 4.538 | 3.795 | 4.836 | 5.876 | 5.132 | 4.576 | 6.765 | 6.640 | 5.693 |
| Receivables | 1.085 | 708 | 717 | 316 | 257 | 389 | 3 | 98 | 21 | 16.877 |
| Cash | 301 | 116 | 257 | 167 | 168 | -4 | 114 | 472 | 933 | 3.571 |
| Shareholders Funds | -23.738 | -26.821 | -33.298 | -21.600 | -17.071 | -8.226 | -5.908 | -3.236 | -1.417 | 2.278 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 62.471 | 63.283 | 68.634 | 56.038 | 52.024 | 40.431 | 36.869 | 36.393 | 35.547 | 141.190 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Euroclin S.r.l.